Royce & Associates’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $133M | Buy |
1,252,310
+17,855
| +1% | +$2.03M | 1.31% | 1 |
|
|
2025
Q4 | $131M | Sell |
1,234,455
-32,636
| -3% | -$3.29M | 1.33% | 1 |
|
|
2025
Q3 | $119M | Buy |
1,267,091
+4,652
| +0.4% | +$433K | 1.18% | 1 |
|
|
2025
Q2 | $109M | Buy |
1,262,439
+8,351
| +0.7% | +$699K | 1.12% | 2 |
|
|
2025
Q1 | $96.7M | Buy |
1,254,088
+14,839
| +1% | +$1.36M | 1.05% | 3 |
|
|
2024
Q4 | $120M | Sell |
1,239,249
-128,525
| -9% | -$12.9M | 1.11% | 1 |
|
|
2024
Q3 | $130M | Sell |
1,367,774
-61,136
| -4% | -$5.34M | 1.18% | 2 |
|
|
2024
Q2 | $119M | Buy |
1,428,910
+1,643
| +0.1% | +$137K | 1.11% | 2 |
|
|
2024
Q1 | $123M | Sell |
1,427,267
-31,824
| -2% | -$2.59M | 1.09% | 2 |
|
|
2023
Q4 | $121M | Buy |
1,459,091
+56,055
| +4% | +$4.11M | 1.11% | 1 |
|
|
2023
Q3 | $101M | Sell |
1,403,036
-21,310
| -1% | -$1.62M | 1.03% | 2 |
|
|
2023
Q2 | $108M | Sell |
1,424,346
-48,686
| -3% | -$3.27M | 1.05% | 2 |
|
|
2023
Q1 | $93M | Sell |
1,473,032
-58,500
| -4% | -$3.43M | 0.93% | 4 |
|
|
2022
Q4 | $83.2M | Sell |
1,531,532
-204,172
| -12% | -$12.1M | 0.87% | 8 |
|
|
2022
Q3 | $99.2M | Sell |
1,735,704
-213,857
| -11% | -$11.9M | 1.12% | 1 |
|
|
2022
Q2 | $90.5M | Buy |
1,949,561
+51,346
| +3% | +$2.69M | 0.93% | 5 |
|
|
2022
Q1 | $109M | Buy |
1,898,215
+100,732
| +6% | +$5.19M | 0.92% | 4 |
|
|
2021
Q4 | $94.7M | Buy |
1,797,483
+169,334
| +10% | +$9.05M | 0.71% | 10 |
|
|
2021
Q3 | $81.7M | Buy |
1,628,149
+129,979
| +9% | +$6.74M | 0.61% | 16 |
|
|
2021
Q2 | $88M | Sell |
1,498,170
-130,910
| -8% | -$8.1M | 0.6% | 11 |
|
|
2021
Q1 | $106M | Buy |
1,629,080
+44,398
| +3% | +$2.73M | 0.71% | 6 |
|
|
2020
Q4 | $87M | Sell |
1,584,682
-18,524
| -1% | -$945K | 0.72% | 9 |
|
|
2020
Q3 | $70.7M | Buy |
1,603,206
+268,280
| +20% | +$11.8M | 0.76% | 11 |
|
|
2020
Q2 | $56.3M | Buy |
1,334,926
+291,376
| +28% | +$11.2M | 0.62% | 21 |
|
|
2020
Q1 | $41.5M | Sell |
1,043,550
-55,685
| -5% | -$2.35M | 0.57% | 35 |
|
|
2019
Q4 | $49M | Sell |
1,099,235
-63,993
| -6% | -$2.46M | 0.44% | 52 |
|
|
2019
Q3 | $39.8M | Buy |
1,163,228
+78,190
| +7% | +$2.71M | 0.37% | 61 |
|
|
2019
Q2 | $40.8M | Sell |
1,085,038
-45,203
| -4% | -$1.55M | 0.37% | 60 |
|
|
2019
Q1 | $34.5M | Buy |
1,130,241
+39,989
| +4% | +$1.22M | 0.29% | 78 |
|
|
2018
Q4 | $30.2M | Buy |
+1,090,252
| New | +$30M | 0.27% | 82 |
|
Other funds holding ACA
VPM
VCM
Royce & Associates's ACA Position: Q1 2026 in Review
Royce & Associates increased its Arcosa (ACA) stake by 1.4% in Q1 2026, buying an estimated $2.03M and bringing the position to 1,252,310 shares worth $133M. The position accounts for 1.31% of the portfolio, ranked #1.
Royce & Associates first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.
- Royce & Associates held 1,252,310 shares of Arcosa worth $133M as of Q1 2026.
- Royce & Associates bought 17,855 Arcosa shares in Q1 2026, an estimated $2.03M.
- Arcosa made up 1.31% of Royce & Associates's portfolio in Q1 2026, its #1 holding.
- Royce & Associates first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.
Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.